Lupartumab Human Monoclonal Antibody
Lupartumabis a research-grade recombinant antibody targeting C4.4A. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
C4.4A, Matrigel-induced gene C4 protein, GPI-anchored metastasis-associated protein C4.4A homolog, MIG-C4, LYPD3, Ly6/PLAUR domain-containing protein 3
UniProt
O95274
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-lambda
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
041593-AP 200 µL
SERTAD2, NT (SERTAD2, KIAA0127, SERTA domain-containing protein 2, Transcriptional regulator interacting with the PHD-bromodomain 2) (AP) discontinued
Sign In for Pricing
View Details 
RC224203L3V 200 µL
CCBE1 (NM_133459) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details